Archford Capital Strategies’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Archford Capital Strategies’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-40,000	Closed	-$118K	–	721
2018 Q2	$118K	Hold	40,000	–	–	0.04%	240
2018 Q1	$118K	Hold	40,000	–	–	0.05%	157
2017 Q4	$118K	Hold	40,000	–	–	0.04%	183
2017 Q3	$118K	Hold	40,000	–	–	0.04%	189
2017 Q2	$112K	Hold	40,000	–	–	0.04%	188
2017 Q1	$76K	Hold	40,000	–	–	0.03%	257
2016 Q4	$70K	Hold	40,000	–	–	0.03%	231
2016 Q3	$108K	Hold	40,000	–	–	0.04%	213
2016 Q2	$94K	Hold	40,000	–	–	0.05%	205
2016 Q1	$129K	Hold	40,000	–	–	0.06%	170
2015 Q4	$192K	Hold	40,000	–	–	0.09%	170
2015 Q3	$222K	Buy	40,000 +20,000	+100%	+$148K	0.17%	108
2015 Q2	$159K	Hold	20,000	–	–	0.11%	125
2015 Q1	$210K	Hold	20,000	–	–	0.14%	117
2014 Q4	$240K	Sell	20,000 -13,055	-39%	-$198K	0.18%	115
2014 Q3	$565K	Hold	33,055	–	–	0.45%	77
2014 Q2	$399K	Hold	33,055	–	–	0.31%	93
2014 Q1	$279K	Buy	+33,055	New	+$267K	0.23%	108

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AOWM

Alpha Omega Wealth Management Richmond, Virginia $657M AUM 22.33% 1-Year Est. Return

Archford Capital Strategies's BDSI Position: Q3 2018 in Review

Archford Capital Strategies sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2018, closing a stake of 40,000 shares — an estimated $118K sold.

Archford Capital Strategies first reported a position in BDSI in Q1 2014 and held it in 18 quarters. The position peaked at $565K in Q3 2014. 83 funds tracked by Wall St. Rank hold BDSI as of Q3 2018.

Archford Capital Strategies reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2018 after selling out during the quarter.
Archford Capital Strategies sold 40,000 BioDelivery Sciences International, Inc. shares in Q3 2018, an estimated $118K.
Archford Capital Strategies first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 18 quarters.
Archford Capital Strategies's BioDelivery Sciences International, Inc. position peaked at $565K in Q3 2014.
83 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2018.

Based on Archford Capital Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.